Evogene rises after its US IPO raises $73.8M

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) - Shares of Evogene climbed in morning trading after the biotechnology company said it raised $73.8 million through its U.S. initial public offering.

Evogene's offering of 5 million shares priced at $14.75 per share. Agribusiness giant Monsanto Co. is paying $12 million for 814,000 shares.

Evogene shares gained $1.30, or 8.8 percent, to $16.05. Earlier the stock rose to $18.10.

The shares are trading on the New York Stock Exchange under the ticker symbol "EVGN."

Evogene Ltd. is based in Rehovot, Israel, and focuses on developing new traits to insert into commercial crops such as corn and soybeans.

The underwriters of the IPO will have the option to buy another 750,000 shares to cover over allotments. Monsanto will own 9.4 percent of the company if those shares are sold.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Most recent Business & Tech stories

Related topics

Business & Tech


Catch up on the top news and features from KSL.com, sent weekly.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

KSL Weather Forecast